![]() |
市場調查報告書
商品編碼
1338554
藥用明膠市場- 副產品(A型、B型)、來源(豬、牛、魚、家禽)、功能(穩定劑、增稠劑、膠凝劑、成膜)、應用(膠囊、片劑、可吸收止血劑)、全球預測2023-2032Pharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032 |
2023年至2032年,全球藥用明膠市場將出現顯著成長。老年人口的不斷擴大和健康問題的日益嚴重,推動了對明膠軟膠囊作為首選劑型的需求。根據聯合國數位圖書館的數據,到 2020 年,全球 65 歲及以上人口估計為 7.27 億。到 2050 年,這一數位預計將增加一倍以上,達到超過 15 億人。預計世界人口中老齡化人口的比例將從 2020 年的 9.3% 上升至 2050 年的 16%。到本世紀中葉,全球六分之一的人口將達到 65 歲或以上。
製藥和營養保健品行業對封裝和控釋系統的需求不斷成長,推動了明膠膠囊的使用。明膠在藥物輸送系統(包括微囊化和緩釋製劑)中的多功能性推動了其應用。此外,嚴格的品質標準、藥品創新和藥品生產的全球成長有助於藥用明膠市場的持續擴張。
整個藥用明膠市場根據產品、來源、功能和地區進行分類。
根據產品情況,A 類細分市場規模將在 2023 年至 2032 年期間顯著擴大。 A 型明膠源自膠原蛋白的酸水解,由於其優異的膠凝和粘合特性,在製藥和營養保健品應用中得到廣泛應用。它通常用於生產膠囊、片劑和其他口服劑型。對 A 型明膠的高需求凸顯了其在藥物輸送系統和製劑開發中的重要性,使其成為藥用明膠市場的重要組成部分。
從來源來看,從 2023 年到 2032 年,魚類領域的藥用明膠市場佔有率將顯著擴大。從魚皮和魚骨中獲得的魚明膠提供了哺乳動物明膠來源的替代品。它的吸引力在於它與不同宗教和飲食要求的兼容性,使其適合更廣泛的消費者群體。隨著消費者偏好轉向非哺乳動物來源,膠囊和包衣等醫藥應用中對魚明膠的需求持續成長,推動了其重要性。
就功能而言,魚明膠行業的成膜部分將在2023-2032年對市場收入做出重大貢獻。明膠能夠形成柔韌且生物相容的薄膜,使其成為片劑、膠囊和其他醫藥產品包衣的首選。這些薄膜包衣具有多種用途,包括掩味、控釋和保護活性成分。隨著製藥公司致力於創新劑型和改善患者體驗,對明膠成膜能力的需求仍然很高。
從區域來看,由於該地區製藥和營養保健品行業的強勁以及膠囊和片劑配方對高品質明膠的需求,到 2032 年,歐洲藥用明膠市場將錄得可觀的估值。對安全有效的藥物輸送系統的嚴格監管要求鼓勵明膠在製藥應用中的使用。此外,對永續採購和製造程序的日益重視與明膠的天然來源相一致,進一步增加了其在歐洲藥用明膠市場的需求。
Global Pharmaceutical Gelatin Market will record a significant growth rate from 2023 to 2032. The expanding elderly population and rising health concerns drive the demand for gelatin-based soft gel capsules as a preferred dosage form. According to the United Nations Digital Library, around the world, there were an estimated 727 million people aged 65 or older in 2020. By 2050, this figure is anticipated to more than double, reaching over 1.5 billion people. The percentage of aging people in the world's population is predicted to rise from 9.3% in 2020 to 16% in 2050. One in six persons worldwide will be 65 years of age or older by the middle of the century.
The increasing pharmaceutical and nutraceutical industries' demand for encapsulation and controlled-release systems fuels the use of gelatin capsules. Gelatin's versatility in drug delivery systems, including microencapsulation and sustained-release formulations, propels its adoption. Additionally, stringent quality standards, pharmaceutical innovations, and the global growth of pharmaceutical production contribute to the Pharmaceutical Gelatin Market's continuous expansion.
The overall Pharmaceutical Gelatin Market is classified based on product, source, function, and region.
Based on the product, the type A segment size will register noticeable expansion throughout 2023-2032. Type A gelatin is derived from the acid hydrolysis of collagen and finds extensive use in pharmaceutical and nutraceutical applications due to its excellent gelling and binding properties. It's commonly used in the production of capsules, tablets, and other oral dosage forms. The high demand for Type A gelatin underscores its significance in drug delivery systems and formulation development, making it a vital component of the pharmaceutical gelatin market.
By source, the pharmaceutical gelatin market share from the fish segment will expand noticeably from 2023 to 2032. Fish gelatin obtained from fish skin and bones offers an alternative to mammalian gelatin sources. Its appeal lies in its compatibility with diverse religious and dietary requirements, making it suitable for a broader consumer base. As consumer preferences shift toward non-mammalian sources, the demand for fish gelatin in pharmaceutical applications, such as capsules and coatings, continues to grow, driving its prominence.
Regarding the function, the film-forming segment of the fish gelatin industry will contribute significantly to the market revenue over 2023-2032. Gelatin's ability to create flexible and biocompatible films makes it a preferred choice for coating tablets, capsules, and other pharmaceutical products. These film coatings serve various purposes, including taste masking, controlled release, and protection of active ingredients. As pharmaceutical companies strive for innovative dosage forms and improved patient experiences, the demand for gelatin's film-forming capabilities remains high.
Regionally, the Europe pharmaceutical gelatin market will record an appreciable valuation by 2032 due to the region's robust pharmaceutical and nutraceutical industries and the need for high-quality gelatin for capsule and tablet formulations. Stringent regulatory requirements for safe and effective drug delivery systems encourage the use of gelatin in pharmaceutical applications. Additionally, the growing emphasis on sustainable sourcing and manufacturing processes aligns with gelatin's natural origin, further boosting its demand in the European pharmaceutical gelatin market.